Literature DB >> 5818670

Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.

J S Cant, D R Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5818670      PMCID: PMC1207306          DOI: 10.1136/bjo.53.4.239

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Guanethidine (Ismelin) in ophthalmology. II. Clinical application in glaucoma.

Authors:  J A OOSTERHUIS
Journal:  Arch Ophthalmol       Date:  1962-06

2.  Adrenergic blockade and the eye signs of thyrotoxicosis.

Authors:  J M Sneddon; P Turner
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

3.  Treatment of dysthyroid ophthalmopathy with local guanethidine.

Authors:  J S Cant; D R Lewis; M T Harrison
Journal:  Br J Ophthalmol       Date:  1969-04       Impact factor: 4.638

4.  Topical guanethidine therapy for endocrine lid retraction.

Authors:  A J Gay; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1966-09

5.  Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.

Authors:  A L Crombie; A A Lawson
Journal:  Br Med J       Date:  1967-12-09

6.  Topical sympatholytic therapy for pathologic lid retraction.

Authors:  A J Gay; M L Salmon; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1967-03
  6 in total
  1 in total

1.  Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.

Authors:  N E Cartlidge; A L Crombie; J Anderson; R Hall
Journal:  Br Med J       Date:  1969-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.